Santgar, founded in 2009, is a promising player in the pharmaceutical and manufacturing sectors, focusing specifically on companion animal drugs and products. With its headquarters in Mexico, Santgar covers a wide spectrum of medical areas, including ophthalmology, dermatology, cardiology, urology, and otorhinolaryngology, in addition to producing anti-pain inflammatories and hormonals.
What distinguishes Santgar is its comprehensive business model that encompasses research, development, manufacture, and marketing. Although Santgar currently operates with a regional sales focus in Mexico, its commitment to science education is extended on a worldwide scale. Despite not having received recent investments, Santgar's established market presence since its inception offers a solid foundation for potential growth opportunities.